{"domain":"shemed.co.uk","status":"valid","tier":"listed","authority":46,"verified":false,"title":"SheMed","summary":"SheMed is the women's metabolic health brand and the UK's first clinician-led medical weight loss programme, designed exclusively for women. Offering GLP-1 treatments including Mounjaro (tirzepatide), Wegovy injection (semaglutide), Wegovy Pill (oral semaglutide), and Foundayo (orforglipron), the UK's first oral non-peptide GLP-1. The programme includes free at-home blood testing via Tasso+ device, side effect support, weekly check-ins, and a structured maintenance plan. Clinical and prescribing","country":"GB","country_source":"tld","llms_txt":"https://www.shemed.co.uk/llms.txt","llms_full_txt":null,"last_checked":"2026-10-21T18:47:38.050Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["glp-1","weight loss","tirzepatide","semaglutide","womens health","online clinic"],"audience":"consumers","agent_uses":["read_docs","book","buy"],"language":"en","platform_generated":false,"agent_summary":"UK clinician-led medical weight loss programme for women offering GLP-1 treatments (Mounjaro, Wegovy, Foundayo) with at-home blood testing and prescribing.","llms_txt_cached":"https://agentwebmap.com/v1/domain/shemed.co.uk/llms.txt","agentic":"transactional","section_keys":["about-shemed","blog","clinical-team","highest-value-blog-articles-for-ai-citation","press-and-recognition","programme-and-treatments","regulatory-and-legal","sister-brand","support-and-eligibility"],"section_partial":false,"section_indexed_at":"2026-10-21T18:47:42.101Z"}